Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN7 | P35236 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | PPARD | Q03181 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | AURKA | O14965 | 1/20 | 0.42 |
| ▸ | GSK3A | P49840 | 1/20 | 0.42 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16294585 | 1.00 | PTPN7 (0.45) | PTPN7MEN1KMT2ANPC1RAB9A | |
| SCHEMBL29897187 | 0.89 | LMNA (0.46) | PTPN7MEN1KMT2ANPC1RAB9A | |
| SCHEMBL29005651 | 0.89 | LMNA (0.46) | PTPN7MEN1KMT2ANPC1RAB9A | |
| Potassium Ion SCHEMBL29643313 | 0.87 | NPC1 (0.43) | MEN1KMT2ANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL5030823 | 0.87 | PTPN7 (0.46) | PTPN7MEN1KMT2ANPC1RAB9A | |
| SCHEMBL5030826 | 0.87 | NPC1 (0.47) | PTPN7MEN1KMT2ANPC1RAB9A | |
| SCHEMBL16285732 | 0.87 | MAPT (0.49) | PTPN7MEN1KMT2ANPC1RAB9A | |
| SCHEMBL3496177 | 0.87 | MEN1 (0.41) | PTPN7MEN1KMT2ANPC1RAB9A | |
| SCHEMBL3496181 | 0.87 | MEN1 (0.41) | PTPN7MEN1KMT2ANPC1RAB9A | |
| SCHEMBL29899356 | 0.87 | PPARD (0.45) | PTPN7MEN1KMT2ANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608872-A2 | SIZE-TUNABLE SYNTHETIC PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME FOR IMMUNE CELL ACTIVATION | Slingshot Biosciences, Inc. (US) | 2025-09-03 | — | — | EP | claimed |
| EP-4577823-A2 | COMPOSITIONS AND METHODS FOR SINGLE WELL MULTIPLEXED CALIBRATION AND COMPENSATION | Slingshot Biosciences, Inc. (US) | 2025-07-02 | — | — | EP | claimed |
| US-20250189428-A1 | COMPOSITIONS AND METHODS FOR SINGLE WELL MULTIPLEXED CALIBRATION AND COMPENSATION | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-06-12 | — | — | US | claimed |
| CN-119744345-A | Compositions and methods for single well multiple calibration and compensation | 弹弓生物科学公司 | 2025-04-01 | — | — | CN | claimed |
| WO-2025049609-A1 | CD34 STEM CELL MIMICS | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-03-06 | — | — | WO | claimed |
| US-20250003960-A1 | APOPTOTIC CELL MIMIC | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-01-02 | — | — | US | claimed |
| US-20240219382-A1 | APOPTOTIC CELL MIMIC | SLINGSHOT BIOSCIENCES, INC. | 2024-07-04 | — | — | US | claimed |
| WO-2024092161-A2 | SIZE-TUNABLE SYNTHETIC PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME FOR IMMUNE CELL ACTIVATION | SLINGSHOT BIOSCIENCES, INC. (US) | 2024-05-02 | — | — | WO | claimed |
| WO-2024064962-A2 | IMMUNO-PCR AND NEXT GENERATION SEQUENCING FOR PRECISE ANTIGEN QUANTITATION | SLINGSHOT BIOSCIENCES, INC. (US) | 2024-03-28 | — | — | WO | claimed |
| WO-2024044593-A2 | COMPOSITIONS AND METHODS FOR SINGLE WELL MULTIPLEXED CALIBRATION AND COMPENSATION | SLINGSHOT BIOSCIENCES, INC. (US) | 2024-02-29 | — | — | WO | claimed |
| US-12576402-B2 | Method and system for recovering products from an emulsion | ECOLE SUPERIEURE DE PHYSIQUE ET DE CHIMIE INDUSTRIELLES DE LA VILLE DE PARIS (FR) | 2026-03-17 | — | — | US | disclosed |
| US-20260061069-A1 | SIZE-TUNABLE SYNTHETIC PARTICLES FOR IMMUNE CELL ACTIVATION | SLINGSHOT BIOSCIENCES INC (US) | 2026-03-05 | — | — | US | disclosed |
| US-20260016390-A1 | COMPOSITIONS AND METHODS FOR CELL-LIKE CALIBRATION PARTICLES | SLINGSHOT BIOSCIENCES, INC. (US) | 2026-01-15 | — | — | US | disclosed |
| US-20250389633-A1 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-12-25 | — | — | US | disclosed |
| US-20250362292-A1 | APOPTOTIC CELL MIMIC | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-11-27 | — | — | US | disclosed |
| US-20220170017-A1 | IN VIVO DELIVERY OF OLIGONUCLEOTIDES | ONCOIMMUNIN INC. | 2022-06-02 | — | — | US | disclosed |
| US-11313782-B2 | Compositions and methods for cell-like calibration particles | SLINGSHOT BIOSCIENCES, INC. (US) | 2022-04-26 | — | — | US | disclosed |
| CN-107615062-B | Hydrogel particles with tunable optical properties and methods of using the same | 弹弓生物科学公司 | 2022-03-18 | — | — | CN | disclosed |
| US-11261443-B2 | In vivo delivery of oligonucleotides | ONCOIMMUNIN INC. (US) | 2022-03-01 | — | — | US | disclosed |
| US-20220033815-A1 | SYSTEMIC IN VIVO DELIVERY OF OLIGONUCLEOTIDES | ONCOIMMUNIN, INC. | 2022-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12576402-B2 | Method and system for recovering products from an emulsion | PLTP, PF4, CD63 | PTPN7 136/4885MEN1 4826/4885KMT2A 4815/4885 |
| US-20260061069-A1 | SIZE-TUNABLE SYNTHETIC PARTICLES FOR IMMUNE CELL ACTIVATION | ICOS, CD47, CD4 | PTPN7 539/4885MEN1 1162/4885KMT2A 2651/4885 |
| US-20260016390-A1 | COMPOSITIONS AND METHODS FOR CELL-LIKE CALIBRATION PARTICLES | CD44, CD63, ACTB | PTPN7 1623/4885MEN1 2144/4885KMT2A 3478/4885 |
| US-20250389633-A1 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | CD4, ICOS, CD69 | PTPN7 206/4885MEN1 3203/4885KMT2A 2367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.